Veridan Wealth LLC: USSG position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Veridan Wealth LLC on USSG, newest first. How the timeline and the estimate are built.
Veridan Wealth LLC held 5,640 USSG shares at 2026-06-30 per its 13F-HR filed 2026-08-10.
the latest 13F is the newest step
- period ended2026-06-3013F 5,640 sharesChange vs previous 13F -45 shares
0.14% of the 13F portfolio, value $391,764.
13F-HR 0001951757-26-001205 filed by Veridan Wealth LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 5,685 sharesChange vs previous 13F -148 shares
0.13% of the 13F portfolio, value $339,287.
13F-HR 0001951757-26-000871 filed by Veridan Wealth LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 5,833 sharesChange vs previous 13F -79 shares
0.12% of the 13F portfolio, value $370,423.
13F-HR 0001951757-26-000451 filed by Veridan Wealth LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 5,912 sharesChange vs previous 13F -210 shares
0.12% of the 13F portfolio, value $362,694.
13F-HR 0001951757-25-001380 filed by Veridan Wealth LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 6,122 sharesChange vs previous 13F -1,355 shares
0.14% of the 13F portfolio, value $308,374.
13F-HR 0001951757-25-000411 filed by Veridan Wealth LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 7,477 sharesChange vs previous 13F not available
0.19% of the 13F portfolio, value $407,292.
13F-HR 0001951757-25-000185 filed by Veridan Wealth LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).